The occurrence of hypospadias in female patients is extremely rare. This paper concerns one woman with this anomaly, operatively treated at the Hospital of Hirosaki University. The case is a 22-year-old female who was admitted for left flank pain and frequent recurrence of urinary inflammation. Radical surgery, utilizing the skin flap of the anterior wall of the vagina and vestibulum for urethroplasty, was performed. The postoperative course was uneventful and the urinary infection was improved. This operative method is almost the same as the method employed for acquired urethrovaginal fistula. This case seems to belong to type 1 of female hypospadia according to Blum’s classification. The etiology of the congenital defect of the urethrovaginal septum still remains obscure. In regard to it, we would like to refer to a local developmental disturbance in type 1 from our clinical study of this patient.

Keywords:
Female hypospadia, Congenital urethrovaginal communication, Female hermaphroditism, Urethroplasty
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.